Washington University School of Medicine joined the Multiple Myeloma Research Consortium (MMRC), an organization of 13 leading U.S. academic centers designed to speed the development of new myeloma therapies, the school said Tuesday.
Washington University School of Medicine serves as a major center for multiple myeloma treatment and research in the St. Louis area.
"As a member of the MMRC, we can provide our patients with access to novel medications that would not otherwise be available," Dr. Ravi Vij, assistant professor of medicine in the division of oncology and a medical oncologist with the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital, said in a statement.
Multiple myeloma is the second most common blood cancer, according to a release.
Washington University in St. Louis is a private teaching and research university. Washington University School of Medicine is affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital.
www.bizjournals.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment